Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Pituitary|November 12, 2025
Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)Brigitte Delemer, Simona M Florea, Benedicte Decoudier, et al.
Nature Communications|September 22, 2020
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11Dayana Abboud, Adrian F Daly, Nadine Dupuis, et al.
Endocrine|October 7, 2016
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine Connections|March 2, 2019
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral centerAdrian F Daly, David A Cano, Eva Venegas-Moreno, et al.
Endocrine Connections|December 23, 2021
Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South AfricaDebra M Gordon, Pablo Beckers, Emilie Castermans, et al.
Endocrine|November 30, 2019
Long-term remission of disseminated parathyroid cancer following immunotherapyMarta Sarquis, Stephen J Marx, Albert Beckers, et al.
Frontiers in Endocrinology|March 14, 2024
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantismManuela Caruso, Diego Mazzatenta, Sofia Asioli, et al.
Revue Medicale De Liege|June 8, 2026
[Climate change and global pollution : endocrine consequences]André Scheen, Albert Beckers
The Journal of Endocrinology|September 23, 2016
A vital region for human glycoprotein hormone trafficking revealed by an LHB mutationIulia Potorac, Adolfo Rivero-Müller, Ashutosh Trehan, et al.
Endocrine Connections|March 10, 2019
AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patientsAdrian F Daly, Liliya Rostomyan, Daniela Betea, et al.
Pageof 17